Pfizer CEO’s Transition Leaves Wall Street Divided on M&A Strategy

(Bloomberg) -- Pfizer Inc. Albert Bourla’s promotion to CEO isn’t surprising and should be viewed positively by investors, analysts say. While Barclays sees the new chief leaning toward more aggres...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.